schemic preconditioning (IPC) is a phenomenon whereby brief intermittent periods of ischemia protect the myocardium against subsequent lethal ischemia. 1 Although the mechanisms responsible for IPC still remain elusive, several factors, such as adenosine, acetylcholine and opioids, which activate protein kinase C, have been implicated in the cardioprotective effect of IPC. 2 Recently, ATP-sensitive potassium (KATP) channels and reactive oxygen species (ROS), among the signaling pathways mediating IPC, have attracted considerable attention. Though the involvement of sarcolemmal KATP channels in IPC was first suggested, 3 subsequent studies have reported that mitochondrial KATP (mitoKATP) channels play a potential role for the cardioprotective effects of KATP channel openers. 4 More recent studies have indicated that the opening of mitoKATP channels induces cardioprotection by generating ROS, which may act as intracellular messengers. 5,6 It has been reported that pretreatment with mitoKATP channel openers 4 or exogenous H2O2 7,8 induces IPC-like protective effects, and that IPC-induced cardioprotection is antagonized by mitoKATP channel inhibitors 9,10 or ROS scavengers. 11,12 These findings support the hypothesis that IPC is mediated through the opening of mitoKATP channels and ROS production. Nevertheless, several investigators have argued against the contribution of mitoKATP channels [13][14][15]17 to IPC. The protective effects of IPC and the mitoKATP channel opener diazoxide (DZ) in whole heart models have been generally evaluated as reduced infarct size and improved contractile function during reperfusion. IPC also has beneficial effects on energy metabolism, such as reduced intracellular acidification during ischemia and postischemic preservation of high-energy phosphates. [18][19][20] Measurement of these parameters may reveal the difference in the cardioprotective mechanisms between IPC and DZ. Moreover, a comparison of IPC and DZ under the same experimental condition would minimize the discrepancy in the results caused by the experimental conditions and models used. However, few studies have compared the effects of IPC and DZ on energy metabolism under the same experimental conditions. Therefore, in the present study we investigated the involvement of the opening of mitoKATP channels and ROS production in IPC-and DZ-induced cardioprotection, using the mitoKATP channel inhibitor 5-hydroxydecanoate (5-HD) and the antioxidant N-acetylcysteine (NAC), in perfused Background Recent studies have implicated the opening of mitochondrial KATP (mitoKATP) channels and the production of reactive oxygen species (ROS) in the cardioprotective mechanism of ischemic preconditioning (IPC).
Methods and ResultsThe involvement of mitoKATP channels and ROS in the cardioprotective effects of both IPC and the mitoKATP channel opener diazoxide (DZ) was investigated in ischemic/reperfused rat hearts. The effects of IPC and DZ on myocardial high-energy phosphate concentrations and intracellular pH (pHi) were also examined using 31...